AGREEMENT FOR THE COLLABORATION BETWEEN CELLTECH R & D LTD and UCB FARCHIM S.A. *CONFIDENTIAL MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.Collaboration Agreement • July 8th, 2004 • Celltech Group PLC • Pharmaceutical preparations • England
Contract Type FiledJuly 8th, 2004 Company Industry JurisdictionScope Collaboration between Celltech and UCB, on a co-exclusive basis (“Co-exclusive” meaning UCB and Celltech only and limited to their respective rights hereunder), for the further development, manufacture and commercialisation of the Product initially for the treatment of rheumatoid arthritis (‘RA’) and Crohn’s disease in humans and for the treatment of any other agreed indications in the Field. The co-exclusive collaboration includes the right to appoint any third party including but not limited to affiliated companies as distributors, except for Japan where UCB shall have the right to appoint sub-licensees.
ORPHAN MEDICAL INC. AND CELLTECH PHARMACEUTICALS LTD. XYREM® LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • June 25th, 2004 • Celltech Group PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2004 Company Industry JurisdictionThis LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of October 29, 2003 (“Effective Date”), by and between Orphan Medical, Inc., a corporation having its principal place of business at 13911 Ridgedale Drive, Suite 250, Minnetonka, Minnesota 55305, USA (together with its Affiliates, “Orphan Medical”), and Celltech Pharmaceuticals, Ltd., a biopharmaceutical company organized under the laws of England having its principal place of business at 208 Bath Road, Slough, Berkshire SL1 3WE, United Kingdom (together with its Affiliates, “Celltech”).
DATE 16 April 2003 SERVICE AGREEMENT BETWEEN CELLTECH GROUP PLC (the “Company”) And DR GORAN ANDO (the “Executive”) ALLEN & OVERYService Agreement • June 14th, 2004 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 14th, 2004 Company Industry
DATED 11TH MAY 1992 MR. PETER V. ALLEN - and - CELLTECH LIMITED TERMS AND CONDITIONS OF EMPLOYMENTEmployment Agreement • June 14th, 2004 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 14th, 2004 Company Industry
AGREEMENT is made the 24th day of September 1998 BETWEENEmployment Agreement • June 14th, 2004 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 14th, 2004 Company Industry
ContractCollaboration Agreement • June 25th, 2004 • Celltech Group PLC • Pharmaceutical preparations • England
Contract Type FiledJune 25th, 2004 Company Industry Jurisdiction*CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *.
ContractAntibody Fragments Contract Manufacturing Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 30th, 2003 Company Industry*CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *.
AGREEMENT DATED 18th December, 2002 REVOLVING CREDIT FACILITY for CELLTECH GROUP PLC arranged by THE ROYAL BANK OF SCOTLAND PLC ALLEN & OVERY London ALLEN & OVERY LondonRevolving Credit Facility • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • Delaware
Contract Type FiledJune 30th, 2003 Company Industry Jurisdiction
OPTION AGREEMENT between PHARMACIA AB and CELLTECH PHARMACEUTICALS LTD. Dated as of July 23, 2002Option Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2003 Company Industry JurisdictionThis OPTION AGREEMENT (the “Option Agreement”) is entered into as of July 23, 2002 by and between Pharmacia AB, a Swedish corporation, (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).
AMENDMENT TO OPTION AGREEMENT AND AGREEMENTOption Agreement and License Agreement • June 25th, 2004 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 25th, 2004 Company IndustryThis Amendment (this “Amendment”) to Option Agreement, dated July 23, 2002, between the parties hereto (the “Option Agreement”) and the Agreement, dated July 23, 2002, between the parties hereto (the “License Agreement”) is made as of April 15, 2004 (the “Date of this Amendment”) by and between Pfizer Health AB (formerly Pharmacia AB), a corporation organized and existing under the laws of Sweden (“Pfizer”), and Celltech Pharmaceuticals Ltd., a corporation organized and existing under the laws of England (“Celltech”).
CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *. AGREEMENT BETWEEN PHARMACIA AB AND CELLTECH PHARMACEUTICALS LTD. DATED July 23, 2002License Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2003 Company Industry JurisdictionThis Agreement (the “Agreement”) is entered into as of July 23, 2002 (the “Effective Date”), by Pharmacia AB, a Swedish corporation (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).
THIS AGREEMENT is made the day of 2002 BETWEEN:Overdraft Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • London
Contract Type FiledJune 30th, 2003 Company Industry Jurisdiction
COLLABORATION AND LICENSE AGREEMENT By and Between PHARMACIA & UPJOHN COMPANY and CELLTECH CHIROSCIENCE LIMITEDCollaboration and License Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • London
Contract Type FiledJune 30th, 2003 Company Industry JurisdictionThis Collaboration and License Agreement dated the 28th day of February, 2001 (the “Execution Date”) is by and between Pharmacia & Upjohn Company, a corporation organized and existing under the laws of the State of Delaware, USA and having a place of business at 100 Route 206 North, Peapack, New Jersey 07977 USA (“Pharmacia”), and Celltech Chiroscience Limited, a corporation organized and existing under the laws of England and having its principal office at 216 Bath Road, Slough, Berkshire SL1 4EN UK (“Celltech”).
MANUFACTURING SERVICES AGREEMENT dated: June 30, 2003 between CELLTECH R&D LIMITED and LONZA LIMITEDManufacturing Services Agreement • June 25th, 2004 • Celltech Group PLC • Pharmaceutical preparations
Contract Type FiledJune 25th, 2004 Company Industry
EUROPE ASSET PURCHASE AGREEMENT BETWEEN PHARMACIA AB AND CELLTECH PHARMACEUTICALS LTD. DATED AS OF SEPTEMBER 2, 2002Asset Purchase Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2003 Company Industry JurisdictionThis Europe Asset Purchase Agreement (the “Agreement”) is entered into as of September 2, 2002 (the “Effective Date”), by Pharmacia AB, a Swedish corporation (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).